Dropbox Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Dropbox Inc trades at $34.15 (market cap $7.42B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.3× Dropbox Inc's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 3,061,580). Which is the better fit depends on your goals — on Pluang, investors hold Dropbox Inc for 97 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| DBX | ROIV | |
|---|---|---|
Market Cap | $7.42B | $24.72B |
Volume | 3,061,580 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $37.74 | $41.81 |
52-Week Low | $22.06 | $16.04 |
Typical Hold Time | 97 Days | 0 Days |
Enterprise Value | $10.29B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $33.08, down 1.93% today, showing bearish technical signals with resistance at $34. Fundamentally, the company maintains strong profitability with 79.72% gross margins and has beaten earnings estimates for three consecutive quarters. Recent news highlights insider selling and a security breach affecting 5,000 accounts in August 2026, while analyst sentiment remains divided with a consensus price target of $26.83.
The outlook remains cautious due to mixed analyst ratings and insider selling activity. While strong cash flow generation and consistent earnings beats provide support, valuation concerns and stagnant revenue growth near $2.5B present headwinds. Key risks include competitive pressures in cloud storage and execution challenges in maintaining market position.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →